Associated Papers
Current Progress on Equilibrative Nucleoside Transporter Function and Inhibitor Design.
Rehan S et al.
Slas Discovery : Advancing Life Sciences R & D, 2019
Residue 33 of human equilibrative nucleoside transporter 2 is a functionally important component of both the dipyridamole and nucleoside binding sites.
Visser F et al.
Molecular Pharmacology, 2005
Identification and mutational analysis of amino acid residues involved in dipyridamole interactions with human and Caenorhabditis elegans equilibrative nucleoside transporters.
Visser F et al.
The Journal of Biological Chemistry, 2005
Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole.
Visser F et al.
The Journal of Biological Chemistry, 2002
Select a paper to view details